Free Trial

TC Biopharm (TCBP) Short Interest Ratio & Short Volume

TC Biopharm logo
$2.50 -0.12 (-4.58%)
Closing price 02/21/2025 04:00 PM Eastern
Extended Trading
$2.48 -0.02 (-0.60%)
As of 02/21/2025 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

TC Biopharm Short Interest Data

TC Biopharm (TCBP) has a short interest of 3,800 shares. This marks a -98.81% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 465,623 shares to cover all short positions.

Current Short Interest
3,800 shares
Previous Short Interest
318,300 shares
Change Vs. Previous Month
-98.81%
Dollar Volume Sold Short
$28,196.00
Short Interest Ratio
0.0 Days to Cover
Last Record Date
January 31, 2025
Outstanding Shares
33,000 shares
Percentage of Shares Shorted
11.52%
Today's Trading Volume
170,524 shares
Average Trading Volume
465,623 shares
Today's Volume Vs. Average
37%
Short Selling TC Biopharm?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for TC Biopharm and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

TCBP Short Interest Over Time

TCBP Days to Cover Over Time

TCBP Percentage of Float Shorted Over Time

TC Biopharm Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
1/31/20253,800 shares $28,196.00 -98.8%N/A0 $7.42
1/15/2025318,300 shares $127,733.79 +75.5%N/A0.1 $0.40
12/31/2024181,400 shares $93,602.40 +474.1%N/A0.1 $0.52
12/15/202431,600 shares $16,716.40 +65.5%N/A0 $0.53
11/30/202419,100 shares $10,694.09 -50.1%N/A0 $0.56
11/15/202438,300 shares $25,354.60 -41.0%N/A0 $0.66
10/31/202464,900 shares $85,668.00 +293.3%N/A0.1 $1.32
10/15/202416,500 shares $83,985.00 -14.1%N/A0 $5.09
9/30/202419,200 shares $100,992.00 -71.0%N/A0.1 $5.26
9/15/202466,300 shares $434,928.00 -3.2%N/A0.3 $6.56
8/31/202468,500 shares $381,545.00 +126.8%N/A0.4 $5.57
8/15/202430,200 shares $109,928.00 +480.8%N/A1.3 $3.64
7/31/20245,200 shares $31,928.00 -84.2%N/A0.3 $6.14
7/15/202432,900 shares $26,244.33 +130.1%N/A0 $0.80
6/30/202414,300 shares $11,787.49 -42.6%N/A0 $0.82
6/15/202424,900 shares $25,896.00 -56.6%N/A0 $1.04
5/31/202457,400 shares $61,992.00 -56.3%N/A0 $1.08
5/15/2024131,200 shares $146,944.00 -30.1%N/A0 $1.12
4/30/2024187,700 shares $268,411.00 -21.0%N/A0 $1.43
4/15/2024237,600 shares $311,256.00 +16.2%N/A0.1 $1.31
3/31/2024204,500 shares $267,895.00 -68.0%N/A0 $1.31
3/15/2024638,700 shares $1.07 million +224.2%N/A0.2 $1.68
2/29/2024197,000 shares $250,190.00 -5.1%N/A0.1 $1.27
2/15/2024207,500 shares $213,725.00 +111.7%N/A0.3 $1.03
1/31/202498,000 shares $106,820.00 +84.6%N/A0.1 $1.09
1/15/202453,100 shares $135,405.00 +127.9%N/A0.4 $2.55
12/31/202323,300 shares $73,861.00 -45.7%N/A0.2 $3.17
12/15/202342,900 shares $110,682.00 -88.2%N/A0.6 $2.58
11/30/2023364,400 shares $134,062.76 +1,312.4%N/A0.5 $0.37
11/15/202325,800 shares $13,274.10 -84.3%N/A0 $0.51
10/31/2023164,000 shares $70,520.00 -11.4%N/A0.5 $0.43
10/15/2023185,000 shares $68,746.00 +2,334.2%N/A0.5 $0.37
9/30/20237,600 shares $3,268.00 -84.9%N/A0 $0.43
9/15/202350,400 shares $23,698.08 +45.2%N/A0.1 $0.47
8/31/202334,700 shares $19,432.00 -16.2%N/A0.1 $0.56
8/15/202341,400 shares $22,219.38 -52.9%N/A0.1 $0.54
7/31/202387,900 shares $54,498.00 -53.3%N/A0.1 $0.62
7/15/2023188,100 shares $96,582.95 -17.1%N/A0.4 $0.51
6/30/2023226,900 shares $122,979.80 -26.4%N/A0.4 $0.54
6/15/2023308,100 shares $188,526.39 +581.6%N/A1 $0.61
Buy this AI Stock Before Elon’s Announcement (Ad)

With Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dust. This isn't just a prediction; it's a calculated shift backed by political support, policy changes, and Musk's proven track record. I've identified a company that is quietly enabling xAI's rapid growth.

Click here to watch my presentation and learn how to invest today.
5/31/202345,200 shares $36,734.04 -6.8%N/A0.2 $0.81
5/15/202348,500 shares $36,326.50 -62.3%N/A0.2 $0.75
4/30/2023128,500 shares $142,635.00 +114.9%N/A0.4 $1.11
4/15/202359,800 shares $83,122.00 -27.1%N/A0.1 $1.39
3/31/202382,000 shares $131,200.00 +821.4%N/A0.1 $1.60
3/15/20238,900 shares $32,841.00 -88.0%N/A0 $3.69
2/28/202374,100 shares $312,702.00 +96.6%N/A0.1 $4.22
2/15/202337,700 shares $262,015.00 -44.5%N/A0 $6.95
1/31/202367,900 shares $347,648.00 -42.7%N/A0.1 $5.12
1/15/2023118,400 shares $530,432.00 +1,096.0%N/A0.2 $4.48
12/30/20229,900 shares $38,115.00 +98.0%N/A0.2 $3.85
12/15/20225,000 shares $21,150.00 -15.3%N/A0.3 $4.23
11/30/20225,900 shares $27,789.00 +110.7%N/A0.4 $4.71
11/15/20222,800 shares $23,800.00 -98.1%N/A0.2 $8.50
10/31/2022148,500 shares $25,987.50 +89.9%N/A0.7 $0.18
10/15/202278,200 shares $17,243.10 -64.1%N/A0.2 $0.22
9/30/2022217,600 shares $61,036.80 -8.2%N/A0.6 $0.28
9/15/2022236,900 shares $77,016.19 +51.7%N/A0.6 $0.33
8/31/2022156,200 shares $51,217.98 -20.6%N/A0.3 $0.33
8/15/2022196,800 shares $83,167.68 +261.8%N/A0.2 $0.42
7/31/202254,400 shares $19,616.64 -68.8%N/A0.1 $0.36
7/15/2022174,600 shares $69,228.90 No ChangeN/A0.2 $0.40

TCBP Short Interest - Frequently Asked Questions

What is TC Biopharm's current short interest?

Short interest is the volume of TC Biopharm shares that have been sold short but have not yet been closed out or covered. As of January 31st, investors have sold 3,800 shares of TCBP short. Learn More on TC Biopharm's current short interest.

Is TC Biopharm's short interest increasing or decreasing?

TC Biopharm saw a decline in short interest in the month of January. As of January 31st, there was short interest totaling 3,800 shares, a decline of 98.8% from the previous total of 318,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does TC Biopharm's short interest compare to its competitors?

Here is how the short interest of companies in the industry of "pharmaceutical products" compare to TC Biopharm: TFF Pharmaceuticals, Inc. (3.95%), Smart for Life, Inc. (11.90%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.21 billion), Charter Communications, Inc. ($4.07 billion), Reddit, Inc. ($3.33 billion), The Kroger Co. ($2.67 billion), Cencora, Inc. ($2.29 billion), Hims & Hers Health, Inc. ($2.17 billion), SoFi Technologies, Inc. ($1.99 billion), Live Nation Entertainment, Inc. ($1.87 billion), Rivian Automotive, Inc. ($1.76 billion), and Moderna, Inc. ($1.60 billion). View all of the most shorted stocks.

What does it mean to sell short TC Biopharm stock?

Short selling TCBP is an investing strategy that aims to generate trading profit from TC Biopharm as its price is falling. TCBP shares are trading down $0.12 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against TC Biopharm?

A short squeeze for TC Biopharm occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of TCBP, which in turn drives the price of the stock up even further.

How often is TC Biopharm's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TCBP, twice per month. The most recent reporting period available is January, 31 2025.




This page (NASDAQ:TCBP) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners